세계의 신경 진단 및 모니터링 장비 시장 규모는 2023년에 118억 1,000만 달러, 2030년까지 173억 3,000만 달러에 달하며, 2024-2030년의 예측 기간에 CAGR로 6.66%의 성장이 전망됩니다. 신경 진단 및 모니터링 장비에 대한 수요의 증가는 주로 신경장애의 유병률 증가와 함께 노년 인구의 증가, 외상성 뇌손상의 이환율 증가, 제품 포트폴리오에서 기술의 진보, 신경장애와 적절한 관리를 향한 조기진단에 관한 환자 의식을 높이는 정부의 구상의 증가에 의해 촉진되고 있습니다.
신경 진단 및 모니터링 장비 시장 역학
세계의 신경 진단 및 모니터링 장비 시장의 성장은 전 세계에서 간질, 뇌졸중, 파킨슨병과 같은 신경 질환의 유병률이 증가함에 따라 가속화되고 있으며, WHO(2022)에 따르면 간질은 만성 뇌질환으로 전 세계에서 약 5,000만 명이 앓고 있으며, 그 중 80%가 저-중저소득 국가로, 전 세계 질병 부담의 큰 비중을 차지하고 있습니다. 중저소득 국가인 만큼 전 세계 질병 부담의 큰 비중을 차지하고 있습니다. 또한 적절한 진단과 치료를 받으면 간질 환자의 70%가 발작을 일으키지 않을 수 있는 것으로 추정됩니다.
또한 전 세계 사람들의 뇌종양과 암 발병률도 증가 추세에 있습니다. 예를 들어 Global Cancer Observatory(2020)의 통계에 따르면 2020년에 전 세계에서 뇌종양과 중추신경계 암이 30만 8,102건 발생했다고 합니다. 따라서 환자 수 증가와 이러한 질병의 조기 진단의 필요성은 신경 진단 및 모니터링 장비에 대한 수요를 증가시킬 수 있으며, 이는 세계 신경 진단 및 모니터링 장비 시장을 더욱 촉진할 것으로 예상됩니다.
또한 첨단 기술을 활용한 신경 진단 기기의 제품 승인은 세계 신경 진단 및 모니터링 장비 시장을 빠르게 성장시킬 가능성이 높습니다. 예를 들어 최근 2020년 1월 Compumedics Limited는 특허받은 DROS; SQUID 센서 시스템을 탑재한 Orion LifeSpanTM MEG에 대한 미국 FDA 승인을 획득했습니다.
그러나 숙련된 전문가 부족, 수술 및 뇌 모니터링 장비의 높은 비용과 같은 특정 요인은 특히 낮은 상환 정책을 가진 선진국에서 신경 진단 및 모니터링 장비에 대한 세계 수요를 제한하는 주요 요인이 되고 있습니다.
신경 진단 및 모니터링 장비 시장 부문 분석
신경 진단 및 모니터링 장비 제품 부문에서는 뇌파계(EEG)가 예측 기간 중 큰 시장을 차지할 것으로 보입니다. 이는 8, 21, 25, 32 등 다양한 채널의 독립형 및 휴대용 EEG 모델을 사용할 수 있기 때문입니다. 또한 EEG 부문의 성장에 기여하는 다른 요인으로는 경량화, 휴대성, 동시 원시 데이터 수집과 같은 기술 발전에 대한 제조업체의 관심 증가가 있습니다. 또한 임상 진료 및 야외 연구용 휴대용 기기에 대한 수요 증가는 이 부문의 성장을 강화할 것으로 예상됩니다.
최근 2019년 니혼코덴은 의식이 없는 환자의 뇌 건강 상태를 신속하게 평가할 수 있는 VitalEEG(TM)를 출시했습니다. 이 시스템은 임상의가 병원내 어디서든 중요한 정보를 평가할 수 있는 원격 액세스 기능과 추가 케이블이 필요 없는 블루투스 통신 기능을 모두 제공합니다.
이러한 제품 출시는 예측 기간 중 신경 진단 및 모니터링 장비 시장의 부문 성장을 가속할 것으로 예상됩니다.
북미가 전체 신경 진단 및 모니터링 장비 시장을 독식할 것으로 예상됩니다.
예측 기간 중 북미가 전체 신경 진단 및 모니터링 장비 시장을 장악할 것으로 예상됩니다. 이러한 우위는 외상성 뇌손상(TBI) 발병률 증가, 의료비 증가, 첨단화된 의료 시스템의 존재에 기인합니다. 또한 적절한 상환 정책도 촉진요인으로 작용하고 있습니다.
예를 들어 CDC의 2022년 보고서에 따르면 2019년 미국에서는 약 6만1,000명이 TBI로 인해 사망했습니다. 또한 연구에 따르면 미국에서 약 170만 명이 외상성 뇌손상을 입은 것으로 추정되며, 그 중 15-19세 청소년과 65세 이상 성인이 외상성 뇌손상을 입을 가능성이 가장 높은 것으로 추정됩니다.
세계의 신경 진단 및 모니터링 장비 시장에 대해 조사분석했으며, 시장 규모와 예측, 촉진요인과 과제, 기업과 제품 개요 등을 제공하고 있습니다.
Neurological Diagnostic and Monitoring Equipment Market By Type (Invasive and Non-Invasive), Product Type (Magneto-Encephalography Devices (Meg), Electroencephalography Devices (Eeg), Transcranial Doppler Sonography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, and Others), Indication (Traumatic Brain Injuries, Epilepsy, Stroke, and Others), End-User (Hospitals, Diagnostic & Imaging Centers, and Others), and Geography is expected to grow at a static CAGR forecast till 2030 due to advances in product portfolio and burgeoning neurological disorder prevalence among the aging population.
The global neurological diagnostic and monitoring equipment market was valued at USD 11.81 billion in 2023, growing at a CAGR of 6.66% during the forecast period from 2024 to 2030, and will reach USD 17.33 billion by 2030. The rise in demand for neurological diagnostic and monitoring equipment is primarily motivated by the increasing prevalence of neurological disorders along with the rising aging population, growing incidence of traumatic brain injuries, technological advancement in the product portfolio, the rising government initiatives to raise awareness among patient regarding neurological disorders and their early diagnosis for proper management, among others.
Neurological Diagnostic and Monitoring Equipment Market Dynamics:
The global neurological diagnostic and monitoring equipment market growth is burgeoning due to the rising prevalence of neurological disorders such as epilepsy, stroke, and Parkinson's among others across the globe. According to WHO 2022, epilepsy is a chronic brain disorder that accounts for a significant proportion of the world's disease burden by affecting around 50 million people across the globe with 80% of the cases in low and middle-income nations. Also, the report mentions that an estimated 70% of people with epilepsy could be seizure-free if properly diagnosed and treated.
Moreover, the incidence of brain tumors and cancer among the world population is also on the rise. For instance, as per the Global Cancer Observatory 2020 statistics, globally there were 308,102 new cases of brain and central nervous system cancer new cases in 2020. Therefore, the rising patient population and the need for early diagnosis of these disorders could increase the demand for neurodiagnostic and monitoring devices which further is expected to boost the global neurological diagnostic and monitoring equipment market.
Further, product approval of technologically advanced neurodiagnostic devices is likely to upsurge the global neurological diagnostic and monitoring equipment market. For example, recently in January 2020, Compumedics Limited received US FDA approval for Orion LifeSpanTM MEG with a patented double relaxation oscillator superconducting quantum interference device (DROS; SQUID) sensor system.
However, certain factors such as the dearth of skilled professionals and the high cost of surgery and devices for brain monitoring are major factors limiting the global demand for neurological diagnostic and monitoring equipment, especially in developed countries with low reimbursement policies.
Neurological Diagnostic and Monitoring Equipment Market Segment Analysis:
Neurological Diagnostic and Monitoring Equipment Market By Type (Invasive and Non-Invasive), Product Type (Magneto-Encephalography Devices (MEG), Electroencephalography Devices (EEG), Transcranial Doppler Sonography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, and Others), Indication (Traumatic Brain Injuries, Epilepsy, Stroke, and Others), End-User (Hospitals, Diagnostic & Imaging Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the neurological diagnostic and monitoring equipment product segment, electroencephalography devices (EEG) hold a significant market during the forecasted period. This is owing to the availability of standalone as well as portable EEG models with different channels such as 8, 21, 25, and 32, among others. Moreover, other factors that contribute to the growth of the EEG segment are the growing focus of manufacturers towards technological advancements, such as lightweight, portability, and the acquisition of raw data simultaneously. Also, the increasing demand for portable devices for clinical practice and outdoor investigation is projected to augment the segment growth.
Furthermore, recently in 2019, Nihon Kohden launched VitalEEG(TM) to rapidly assess brain health in unconscious patients. The system provides both remote access functionality, so clinicians can assess critical information from anywhere in the hospital, and Bluetooth communication, eliminating the need for additional cables.
Thus such product launches are also expected to fuel the segmental growth of the neurological diagnostic and monitoring equipment market during the forecasted period.
North America is expected to dominate the overall Neurological Diagnostic and Monitoring Equipment Market:
North America is expected to dominate the overall neurological diagnostic and monitoring equipment market during the forecast period. This domination is due growing incidence of traumatic brain injuries (TBI), the increased healthcare expenditure along with the presence of well-developed and advanced healthcare systems in the region. Moreover, adequate reimbursement policies are the driving factors.
For instance, as per the CDC 2022 report, in 2019, there were nearly 61,000 TBI-related deaths in the US. Also, research studies have estimated that in the US, approximately 1.7 million people suffer a traumatic brain injury, with adolescents between ages 15 and 19 and adults aged 65 and older among the most likely to sustain a traumatic brain injury.
The presence of key market players such as Masimo Corporation, Compumedics Limited, and Natus Medical Incorporated, among others in the region is likely to boost the neurological diagnostic and monitoring equipment market.
Moreover, an increase in product approval in the region is also a driving factor for the Neurological Diagnostic and Monitoring Equipment in the region. For instance, in August 2020, Masimo announced that O3® Regional Oximetry has received FDA clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains.
Thus, the aforementioned factors are likely to upsurge the market for neurological diagnostic and monitoring equipment in the region.
Neurological Diagnostic and Monitoring Equipment Market Key Players:
Some of the key market players operating in the neurological diagnostic and monitoring equipment market include Natus Medical, Inc., Nihon Kohden Corporation, Koninklijke Philips N.V., Compumedics Limited, Croton Healthcare, Ricoh, Elekta AB, Integra LifeSciences, RAUMEDIC AG, Masimo, Cadwell® Industries Inc., Nonin, Neurosoft, Brain Scientific, Inc., Recorders & Medicare Systems Pvt Ltd (RMS), Rimed, Allengers, Medtronic, Edwards Lifesciences Corporation., Ybrain, INC, and others.
Recent Developmental Activities in the Neurological Diagnostic and Monitoring Equipment Market:
In March 2022, Brain Scientific received FDA Clearance for Next-Gen NeuroCap(TM) EEG Headset, an advanced Electroencephalogram (EEG) electrode array used to obtain rapid EEGs in routine clinical and research settings where the recording of STAT EEGs is desired.
In October 2020, MEGIN announced Japan Expansion by launching MEGIN KK in Tokyo.
In December 2019, Raumedic, a medical technology manufacturer, launched a new home-use device, named Raumed Home ICP, for intracranial pressure (ICP) monitoring. The product was developed for patients suffering from hydrocephalus.
Key Takeaways from the Neurological Diagnostic and Monitoring Equipment Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global neurological diagnostic and monitoring equipment market.
Various opportunities available for the other competitor in the neurological diagnostic and monitoring equipment market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for neurological diagnostic and monitoring equipment market growth in the coming future?
Target Audience who can be benefited from Neurological Diagnostic and Monitoring Equipment Market Report Study
Neurological Diagnostic and Monitoring Equipment providers
Research organizations and consulting companies
Neurological Diagnostic and Monitoring Equipment-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in neurological diagnostic and monitoring equipment
Various End-Users who want to know more about the neurological diagnostic and monitoring equipment market and the latest technological developments in the neurological diagnostic and monitoring equipment market.
Frequently Asked Questions for Neurological Diagnostic and Monitoring Equipment Market:
Neurological Diagnostic and Monitoring Equipment are the devices used for the diagnosis of neurological disorders such as stroke, migraine, epilepsy, Parkinson's disease, and ischemic stroke, among others. There are various equipment available in the market such as EEG, MEG, Cerebral Oximeters, among others.
The global Neurological Diagnostic and Monitoring Equipment Market was valued at USD 11.81 billion in 2023, growing at a CAGR of 6.66% during the forecast period from 2024 to 2030, and will reach USD 17.33 billion by 2030.
The major factors driving the demand for Neurological Diagnostic and Monitoring Equipment are the growing prevalence of neurological disorders coupled with the rising geriatric population, the increasing incidence of traumatic brain injuries, and the launch of technically advanced products in the market.
Some of the key market players operating in the neurological diagnostic and monitoring equipment market include natus medical, inc., Nihon Kohden Corporation, Koninklijke Philips N.V., Compumedics Limited, Croton Healthcare, Ricoh, Elekta AB, Integra LifeSciences, RAUMEDIC AG, Masimo, Cadwell® Industries Inc., Nonin, Neurosoft, Brain Scientific, Inc., Recorders & Medicare Systems Pvt Ltd (RMS), Rimed, Allengers, Medtronic, Edwards Lifesciences Corporation., Ybrain, INC, and others.
North America is expected to dominate the overall neurological diagnostic and monitoring equipment market during the forecast period, 2024-2030. this domination is because of the increased healthcare expenditure along with the presence of well-developed and advanced healthcare systems in the region. Moreover, adequate reimbursement policies are the driving factors.